PSA
58
2
EL
25
4
PVH
62
5
SE
61
-4
COF
60
2
AA
48
-12
CCI
31
3
AN
58
4
GPC
40
3
IR
66
3
VMC
57
4
IBM
58
-2
PPL
54
-5
NDAQ
62
2
APD
59
2
MSFT
50
3
KMB
39
2
JPM
69
2
NKE
36
6
LRCX
43
-2
PSA
58
2
EL
25
4
PVH
62
5
SE
61
-4
COF
60
2
AA
48
-12
CCI
31
3
AN
58
4
GPC
40
3
IR
66
3
VMC
57
4
IBM
58
-2
PPL
54
-5
NDAQ
62
2
APD
59
2
MSFT
50
3
KMB
39
2
JPM
69
2
NKE
36
6
LRCX
43
-2
Financhill
Back

Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

PSTV
Plus Therapeutics

Last Price:
1.20
Seasonality Move:
7.34%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
35
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy, Sell or Hold?

  • The current Plus Therapeutics [PSTV] share price is $1.18. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSTV Stock Price Chart

What is Plus Therapeutics's stock price today?

  • The Plus Therapeutics share price today is $1.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PSTV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 40.32 Sell
Chaikin Money Flow: 41852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.22 - 1.38) Sell
Bollinger Bands (100): (1.29 - 1.67) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

PSTV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Sell
20-day SMA: 1.28 Sell
50-day SMA: 1.38 Sell
200-day SMA: 1.7 Sell
8-day EMA: 1.22 Sell
20-day EMA: 1.27 Sell
50-day EMA: 1.36 Sell
200-day EMA: 1.73 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Plus Therapeutics Earnings Growth & PSTV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.03 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):